ARTICLE | Clinical News
CoFactor regulatory update
October 18, 2004 7:00 AM UTC
EMEA granted Orphan Drug designation to CoFactorT, a 5,10-methylenetetrahydrofolate form of folic acid, to treat pancreatic cancer. ANX plans to submit a Clinical Trial Application (CTA) in 1Q05 to st...